Response to Imatinib in e13a2 Versus e14a2 BCR-ABL Fusion Transcripts in Chronic Myeloid Leukemia Saudi Patients

被引：1
作者：
Elbjeirami, Wafa M. [1 ]
Alabdulwahab, Amal S. [2 ]
Elsayed, Hussein G. [2 ]
Abdelghaffer, Nermeen Adel [2 ,3 ]
Elnagdi, Noha [4 ,5 ]
Al-Jedani, Hanadi [4 ]
Abd Allatif, Nahla [4 ,5 ]
Al Shaikh, Abdulaziz [4 ]
Al-Allaf, Faisal [1 ]
机构：
[1] Mol Diagnost Sect, Dept Lab & Blood Bank, King, WI, Saudi Arabia
[2] Dept Hematol, King, WI, Saudi Arabia
[3] Ain Shams Univ, Dept Hematol, Cairo, Egypt
[4] Hematol Sect, Dept Lab & Blood Bank, King, WI, Saudi Arabia
[5] Natl Canc Inst Cairo Univ, Dept Clin Pathol, Cairo, Egypt
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5453.5453
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5453
引用
收藏
页数：5
相关论文
共 50 条
[41]   Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript [J].
Tchirkov, A ;
Couderc, JL ;
Périssel, B ;
Goumy, C ;
Regnier, A ;
Uhrhammer, N ;
Verrelle, P ;
Berger, M .
LEUKEMIA, 2006, 20 (01) :167-168
[42]   Comparable b2a2/e13a2 and b3a2/e14a2 Reporting in BCR-ABL Assay When Calibrated By Who Is and By IVT-RNA Copy Number [J].
Wei, Huilin ;
Tran, Tran ;
Shridhar, Krupa ;
Wang, Nick ;
Day, Gwo-Jen .
BLOOD, 2023, 142
[43]   Assessment of quantitative polymerase chain reaction for BCR-ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology? [J].
Dominy, Katherine M. ;
Claudiani, Simone ;
O'Hare, Matthew ;
Szydlo, Richard ;
Gerrard, Gareth ;
Foskett, Pierre ;
Foroni, Letizia ;
Milojkovic, Dragana ;
Apperley, Jane F. ;
Khorashad, Jamshid .
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (01) :52-62
[44]   Evaluation of BCR-ABL/ABL Ratio Increase That Corresponds to BCR-ABL Mutation In Chronic Myeloid Leukemia Patients Treated by Imatinib [J].
Tsaur, Grigory ;
Ivanova, Anna ;
Popov, Alexander ;
Yakovleva, Yulia ;
Riger, Tatyana ;
Plekhanova, Olga ;
Ivanets, Yulia ;
Misyurin, Andrey ;
Suchkova, Marina ;
Shorikov, Egor ;
Saveliev, Leonid ;
Fechina, Larisa .
BLOOD, 2010, 116 (21) :1402-1402
[45]   Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant [J].
Qin, Ya Zhen ;
Jiang, Bin ;
Jiang, Qian ;
Zhang, Yan ;
Jiang, Hao ;
Li, Jin Lan ;
Zhu, Hong Hu ;
Li, Ling Di ;
Liu, Yan Rong ;
Chen, Shan Shan ;
Huang, Xiao Jun .
ACTA HAEMATOLOGICA, 2008, 120 (03) :146-149
[46]   Chronic Myelogenous Leukemia with the e6a2 BCR-ABL and Lacking Imatinib Response: Presentation of Two Cases [J].
Vefring, Hege K. ;
Gruber, Franz X. E. ;
Wee, Line ;
Hovland, Randi ;
Hjorth-Hansen, Henrik ;
Dahl, Tobias Gedde ;
Meyer, Peter .
ACTA HAEMATOLOGICA, 2009, 122 (01) :11-16
[47]   A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript [J].
Li, Xiaoqing ;
Yang, Jing ;
Chen, Xiangjun ;
Liu, Jun ;
Li, Hongrui ;
Zheng, Jine ;
He, Yanli ;
Chen, Zhong ;
Huang, Shiang .
CANCER GENETICS AND CYTOGENETICS, 2007, 176 (02) :166-168
[48]   Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts [J].
Langabeer, Stephen E. ;
Crampe, Mireille ;
Kelly, Johanna ;
Fadalla, Kamal ;
Connaghan, Gerard ;
Conneally, Eibhlin .
LEUKEMIA RESEARCH, 2010, 34 (08) :E204-E205
[49]   Effectiveness of First and Second Line Nilotinib in Chronic Myeloid Leukemia (CML) Patients with Atypical e1a2 BCR-ABL Transcripts [J].
Gui, Xiaomin ;
Pan, Jinlan ;
Qiu, Huiying ;
Cen, Jiannong ;
Xue, Yongquan ;
Chen, Suning ;
He, Jun ;
Shen, Hongjie ;
Yao, Li ;
Zhang, Jun ;
Wu, Yafang ;
Wu Depei .
BLOOD, 2014, 124 (21)
[50]   Poor response to imatinib therapy in chronic myeloid leukaemia expressing variant BCR-ABL transcripts [J].
Dutt, T. ;
Lucas, C. M. ;
Wang, L. ;
Clark, R. E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 :66-66
12345